A synthetic strategy has been developed that provides easy access to structurally diverse analogues of naturally occurring antibiotics, providing a fresh means of attack in the war against drug-resistant bacteria. See Article p.338
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Seiple, I. B. et al. Nature 533, 338–345 (2016).
Wright, P. M., Seiple, I. B. & Myers, A. G. Angew. Chem. Int. Edn 53, 8840–8869 (2014).
Keasling, J. D., Mendoza, A. & Baran, P. S. Nature 492, 188–189 (2012).
Parenty, A., Moreau, X., Niel, G. & Campagne, J.-M. Chem. Rev. 113, PR1–PR40 (2013).
Kuttruff, C. A., Eastgate, M. D. & Baran, P. S. Nat. Prod. Rep. 31, 419–432 (2014).
Seiple, I. B., Mercer, J. A. M., Sussman, R. J., Zhang, Z. & Myers, A. G. Angew. Chem. Int. Edn 53, 4642–4647 (2014).
Zhang, Z., Fukuzaki, T. & Myers, A. G. Angew. Chem. Int. Edn 55, 523–527 (2016).
Author information
Authors and Affiliations
Corresponding author
Related links
Rights and permissions
About this article
Cite this article
Yan, M., Baran, P. Fighting evolution with chemical synthesis. Nature 533, 326–327 (2016). https://doi.org/10.1038/533326a
Published:
Issue Date:
DOI: https://doi.org/10.1038/533326a
This article is cited by
-
The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly
Antonie van Leeuwenhoek (2017)
